An experimental compound being developed by a Madison company could help doctors better detect and treat many types of cancer, a new UW-Madison study says. The compound, which is thought not to accumulate in healthy cells, ?is essentially a cancer-homing agent to which we can attach many different payloads,? Dr. John Kuo, a UW-Madison brain surgeon and an author of the study, said.
Office of Strategic Communication